到2025年，合法的大麻市场预计将增长到1460亿美元以上，爆炸性的增长使大麻产业成为绝佳长期投资。奥驰亚，星座公司和IIPR这三家企业有希望从大麻市场在未来十年的急剧扩张中获利。
The ability to identify powerful growth trends is an important aspect of successful long-term investing. Businesses with strong competitive positions in rapidly growing industries can compound investors' returns for years and even decades.
确定强劲增长趋势的能力是成功长期投资的一个重要方面。在快速增长的行业中拥有强大竞争地位的企业，可以在数年乃至几十年内为投资者带来丰厚的回报。
Perhaps no other industry is expanding faster than marijuana. The legal marijuana market will grow to more than $146 billion by 2025, according to Grand View Research, up from only $7 billion in 2016.
也许没有哪个行业比大麻发展得更快。根据 Grand View Research 的数据，到2025年，合法的大麻市场将增长到1460亿美元以上，而2016年只有70亿美元。
This explosive growth makes the marijuana industry fertile ground for finding excellent long-term investment opportunities. The following three businesses are particularly well positioned to profit from the cannabis market's torrid expansion in the coming decade.
这种爆炸性的增长使大麻产业成为寻找优秀长期投资机会的沃土。以下三家企业特别有能力从大麻市场在未来十年的急剧扩张中获利。
Altria (NYSE: MO) may not be the first company that comes to mind when thinking about marijuana, but the tobacco titan is likely to emerge as a powerful force within this booming industry.
奥驰亚（ NYSE ： MO ）可能不是第一个想到大麻的公司，但烟草巨头可能会成为这个蓬勃发展的行业中的强大力量。
Altria made an aggressive move into the cannabis market with its $1.8 billion investment in Cronos Group (NASDAQ: CRON). Altria now owns a 45% stake in the Canadian marijuana producer, along with warrants that give it the right to boost its stake to 55%.
奥驰亚在克罗诺斯集团（ NASDAQ ： CRON ）投资18亿美元，大举进军大麻市场。奥驰亚现在拥有加拿大大麻生产商45%的股份，同时还拥有将其股份提高到55%的权利。
Altria's regulatory and marketing expertise should help Cronos Group capture a larger share of the global marijuana market in the coming years. Additionally, the strong and steady cash flow Altria produces from its core tobacco business to help lower its risk profile for investors. Altria could also use some of this cash to acquire the remainder of Cronos Group's shares in the future, as well as other cannabis-focused businesses. Altria's investment in Cronos Group may be its first foray in the marijuana industry -- but it's unlikely to be its last.
奥驰亚的监管和营销专业知识应有助于克罗诺斯集团在未来几年占据全球大麻市场的更大份额。此外，奥驰亚的强劲而稳定的现金流来自其核心烟草业务，以帮助降低投资者的风险状况。奥驰亚还可以用部分现金收购克罗诺斯集团未来的剩余股份，以及其他以大麻为重点的业务。奥驰亚对克罗诺斯集团的投资可能是其在大麻产业的首次尝试，但不太可能是最后一次。
Notably, Altria also pays a bountiful dividend, providing its shareholders with a reliable and steadily growing income stream. Its shares currently yield 5.8% and can be had for only 12 times forward earnings -- a bargain price for such a high-quality business.
值得注意的是，奥驰亚也支付了丰厚的股息，为股东提供了可靠且稳定增长的收入流。它的股票目前收益率为5.8%，只能获得12倍的预期收益——对于这样一个高质量的企业来说，这是一个便宜的价格。
Now that it is becoming legal in more locations, some people may choose to use marijuana as a substitute for alcohol. Alcoholic beverage behemoth Constellation Brands (NYSE: STZ)(NYSE: STZ-B) knows this. It also had the foresight to partner with a leading marijuana producer, thereby transforming it into a powerful ally, rather than a threat.
现在大麻在更多的地方变得合法，一些人可能会选择用大麻来代替酒精。酒精饮料巨头星座品牌（ NYSE ： STZ ）（ NYSE ： STZ-B ）知道这一点。它也有远见与领先的大麻生产商合作，从而将其转变为强大的盟友，而不是威胁。
Constellation Brands has invested more than $4 billion in top Canadian marijuana producer Canopy Growth (NYSE: CGC), giving it a 38% stake in the fast-growing company. The capital injection is helping Canopy Growth add production capacity and expand internationally. Constellation and Canopy are also expected to work together to produce cannabis-infused beverages.
Constellation Brands 已向加拿大最大的大麻生产商 Canopy Growth 投资超过40亿美元（ NYSE ： CGC ），使其拥有这家快速增长公司38%的股份。此次注资有助于 Canopy Growth 增加产能，并在国际上扩张。预计星座和 Canopy 也将合作生产大麻饮料。
$奥驰亚(MO)$ $星座品牌(STZ)$ $Innovative(IIPR)$
